Us Bancorp \De\ Biotechnology

Us Bancorp \De\

$78.3 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
STOK Stoke Therapeutics, Inc.	$870M	$2,000 0.0% of portfolio	259	Q2 2025 Reduced 97.69%
TSHA Taysha Gene Therapies, Inc.	$157M	$2,000 0.0% of portfolio	975	Q2 2025 Added 4.73%
ANIX Anixa Biosciences Inc	$91.4M	$1,000 0.0% of portfolio	400	Q2 2022 Reduced 97.07%
AURA Aura Biosciences, Inc.	$189M	$1,000 0.0% of portfolio	218	Q2 2025 New
CDXC Chroma Dex Corp.	$420M	$1,000 0.0% of portfolio	169	Q2 2025 Added 704.76%
IOVA Iovance Biotherapeutics, Inc.	$374M	$1,000 0.0% of portfolio	1,147	Q2 2025 Reduced 97.5%
ITOS I Teos Therapeutics, Inc.	$361M	$1,000 0.0% of portfolio	149	Q2 2025 Reduced 76.57%
SANA Sana Biotechnology, Inc.	$575M	$1,000 0.0% of portfolio	670	Q2 2025 Added 10.56%
VIR Vir Biotechnology, Inc.	$680M	$1,000 0.0% of portfolio	306	Q2 2025 Reduced 80.09%
ZNTL Zentalis Pharmaceuticals, Inc.	$91.2M	$1,000 0.0% of portfolio	1,164	Q2 2025 Reduced 87.48%
MGTX Meira G Tx Holdings PLC	$344M	$0 0.0% of portfolio	38	Q4 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$135M	$0 0.0% of portfolio	200	Q2 2025 New
ALLO Allogene Therapeutics, Inc.	$164M	$0 0.0% of portfolio	184	Q2 2025 Reduced 97.36%
ARQT Arcutis Biotherapeutics, Inc.	$1.08B	$0 0.0% of portfolio	62	Q2 2025 Reduced 47.9%
ATHA Athira Pharma, Inc.	$14.7M	$0 0.0% of portfolio	815	Q1 2024 New
CRBU Caribou Biosciences, Inc.	$112M	$0 0.0% of portfolio	183	Q2 2025 Reduced 98.96%
COGT Cogent Biosciences, Inc.	$843M	$0 0.0% of portfolio	31	Q2 2025 Reduced 86.28%
CRMD Cor Medix Inc.	$544M	$0 0.0% of portfolio	16	Q2 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$544M	$0 0.0% of portfolio	24	Q2 2025 Added 20.0%
EYPT Eye Point Pharmaceuticals, Inc.	$483M	$0 0.0% of portfolio	29	Q2 2025 New
IGMS Igm Biosciences, Inc.	$36.8M	$0 0.0% of portfolio	17	Q1 2025 Reduced 34.62%
IMNM Immunome Inc.	$108M	$0 0.0% of portfolio	21	Q1 2025 New
MREO Mereo Biopharma Group PLC	$221M	$0 0.0% of portfolio	13	Q2 2024 Reduced 96.85%
OLMA Olema Pharmaceuticals, Inc.	$301M	$0 0.0% of portfolio	30	Q2 2025 New
OMER Omeros Corp	$267M	$0 0.0% of portfolio	100	Q2 2025 Added 488.24%
ORIC Oric Pharmaceuticals, Inc.	$413M	$0 0.0% of portfolio	28	Q2 2025 Added 27.27%
PBYI Puma Biotechnology, Inc.	$213M	$0 0.0% of portfolio	200	Q3 2021 Reduced 60.78%
SGMO Sangamo Therapeutics, Inc	$81.4M	$0 0.0% of portfolio	11	Q1 2025 Reduced 52.17%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	926	Q2 2025 Added 1.2%
SPRO Spero Therapeutics, Inc.	$69.4M	$0 0.0% of portfolio	151	Q1 2025 Reduced 97.07%
VERA Vera Therapeutics, Inc.	$678M	$0 0.0% of portfolio	6	Q2 2025 Reduced 89.83%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.